what is tirzepatide and semaglutide vs. Semaglutide: Which Best for Weight Loss? There is no one-size-fits-all approach
Description
Some may experience acne, rashes, or urticaria, while others might notice changes in facial skin texture, such as increased dryness or oiliness
Based on the GLP-1 and GIP receptors it targets, the expected effects are the same gastrointestinal package as the rest of the class: nausea, vomiting, constipation, and less appetite, worst while the dose is climbing
2023;46(Supplement_1):S140-S157
Well assess if its right for you during your consultation
Retatrutide currently progresses through Phase 3 clinical trials, which typically require 18-24 months for completion plus additional time for FDA and Health Canada review
New frontiers in obesity treatment: GLP-1 and nascent nutrient-stimulated hormone-based therapeutics
